title: Mutation frequency is reduced in the cerebellum of Big Blue mice overexpressing a human wild type SOD1 gene.
abstract: Amyotrophic lateral sclerosis (ALS) is a progressive paralytic disorder caused by motor neuron degeneration. A similar disease phenotype is observed in mice overexpressing a mutant human hSOD1 gene (G93A, 1Gurd(1)). Mice transgenic for lacI (Big Blue) and human mutant (1Gurd(1), Mut hSOD1) or wild type (2Gur, Wt hSOD1) SOD1 genes were used to examine spontaneous mutation, oxidative DNA damage, and neurodegeneration in vivo. The frequency and pattern of spontaneous mutation were determined for forebrain (90% glia), cerebellum (90% neurons) and thymus from 5-month-old male mice. Mutation frequency is not elevated significantly and mutation pattern is unaltered in Mut hSOD1 mice compared to control mice. Mutation frequency is reduced significantly in the cerebellum of Wt hSOD1 mice (1.6x10(-5); P=0.0093; Fisher's Exact Test) compared to mice without a human transgene (2.7x10(-5)). Mutation pattern is unaltered. This first report of an endogenous factor that can reduce in vivo, the frequency of spontaneous mutation suggests potential strategies for lowering mutagenesis related to aging, neurodegeneration, and carcinogenesis.
authors.affiliation: Department of Molecular Genetics, City of Hope/Beckman Research Institute, Duarte, CA 91010, USA.
authors.forename: M
authors.initials: M
authors.lastname: Kunishige
authors.forename: K A
authors.initials: KA
authors.lastname: Hill
authors.forename: A M
authors.initials: AM
authors.lastname: Riemer
authors.forename: K D
authors.initials: KD
authors.lastname: Farwell
authors.forename: A
authors.initials: A
authors.lastname: Halangoda
authors.forename: E
authors.initials: E
authors.lastname: Heinmöller
authors.forename: S R
authors.initials: SR
authors.lastname: Moore
authors.forename: D M
authors.initials: DM
authors.lastname: Turner
authors.forename: S S
authors.initials: SS
authors.lastname: Sommer
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D000818:Animals; D002531:Cerebellum / Q000378:metabolism*; D004249:DNA Damage; D004195:Disease Models, Animal; D005838:Genotype; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D051379:Mice; D008817:Mice, Mutant Strains; D008822:Mice, Transgenic; D009154:Mutation; D010084:Oxidation-Reduction; D010641:Phenotype; D016133:Polymerase Chain Reaction; D016548:Prosencephalon / Q000378:metabolism; D013116:Spinal Cord / Q000378:metabolism; D013482:Superoxide Dismutase / Q000235:genetics* / Q000378:metabolism; D000072105:Superoxide Dismutase-1; D013950:Thymus Gland / Q000378:metabolism; D019076:Transgenes
chemical_list: C000606290:SOD1 protein, human; C000606291:Sod1 protein, mouse; D013482:Superoxide Dismutase; D000072105:Superoxide Dismutase-1